# reload+after+2024-01-22 09:31:53.077062
address1§1800 Bridge Parkway
city§Redwood City
state§CA
zip§94065
country§United States
phone§650 251 0005
website§https://nevro.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
fullTimeEmployees§1087
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Roderick H. MacLeod', 'age': 56, 'title': 'Senior VP & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 729607, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kashif  Rashid', 'age': 49, 'title': 'Senior VP, General Counsel & Corporate Secretary', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 703353, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin R. Thornal', 'age': 49, 'title': 'President, CEO & Director', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard B. Carter', 'age': 52, 'title': 'Chief Accounting Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christofer  Christoforou', 'age': 53, 'title': 'Senior Vice President of Technical Operations', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 367404, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Geeta  Kaveti', 'title': 'VP and Chief Compliance & Privacy Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jon R. Shear', 'title': 'Senior Vice President of Corporate Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Meredith  Vornholt', 'title': 'Vice President of Global Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Shana D. Ross M.B.A.', 'title': 'Senior VP & Chief of Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David  Caraway M.D., Ph.D.', 'age': 66, 'title': 'Senior VP & Chief Medical Officer', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§6
compensationRisk§10
shareHolderRightsRisk§4
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.012
priceToSalesTrailing12Months§1.6604359
currency§USD
dateShortInterest§1702598400
forwardEps§-2.32
pegRatio§0.02
exchange§NYQ
quoteType§EQUITY
shortName§Nevro Corp.
longName§Nevro Corp.
firstTradeDateEpochUtc§1415284200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§184e045d-fc44-3c44-989b-8184a242fcbf
gmtOffSetMilliseconds§-18000000
targetHighPrice§40.0
targetLowPrice§13.0
targetMeanPrice§21.32
targetMedianPrice§20.0
recommendationMean§3.1
recommendationKey§hold
numberOfAnalystOpinions§17
quickRatio§4.881
grossMargins§0.67122
ebitdaMargins§-0.23749
trailingPegRatio§None
